Nukkleus (NUKKW) | Stock Overview & Key Data
Nukkleus Performance Comparison
Stock Range
Today's Range
Low: $0.03
High: $0.03
on August 22, 2025
52 Week Range
Low: $0.03
High: $0.03
on August 22, 2025
on August 22, 2025
All-Time High: $0.20 on December 25, 2023
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$901.4M
EPS
-0.02
P/E Ratio (TTM)
N/A
Forward P/E
N/A
P/B Ratio
N/A
PEG Ratio
N/A
Div. Yield
N/A
ROE
120.02%
Beta
-6.042
Debt to Equity
-0.04
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-134.75%
Profit Margin
16.89%
Returns and Earnings
Return on Assets (TTM)
-864.83%
Return on Equity (TTM)
120.02%
EBITDA
$0
Net Income (TTM)
$-532.8M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$2.82
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
-100.00%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Nukkleus NUKKW | 901.35M Small-cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 166.67% | -38.46% | -38.46% |
| Salesforce CRM | 235.01B Mega-cap | 2.41% | -5.80% | -12.40% | -19.47% | -24.91% | -5.95% | 50.27% | -8.41% |
| Intuit INTU | 200.06B Mega-cap | -7.55% | -13.58% | -0.51% | 16.82% | 6.40% | 6.91% | 47.76% | 91.46% |
| Eplus PLUS | 1.92B Small-cap | 0.75% | 11.02% | 12.13% | 10.12% | -0.46% | -22.88% | 49.90% | 92.37% |
| Matterport MTTR | 1.76B Small-cap | 0.75% | 3.07% | 13.03% | 21.17% | 10.25% | N/A | N/A | N/A |
| Olo OLO | 1.73B Small-cap | 0.20% | 0.99% | 16.25% | 53.37% | 32.68% | 85.66% | 32.86% | -65.67% |
Ownership & Short Interest
Insider Ownership
N/A
Institutional Ownership
N/A
Shares Short
82K
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
63K
Average 90-Day Volume
241K
Nukkleus Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Nukkleus would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is NUKKW's 52-week high and low?
- In the last 52 weeks, Nukkleus reached a high of $0.03 (on August 22, 2025) and a low of $0.03 (on August 22, 2025).
- What is the market cap and P/E ratio for NUKKW?
- Curious about Nukkleus's size and valuation? Its market capitalization stands at 901.35M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.
- Does NUKKW pay dividends? If so, what's the yield?
- As for dividends, Nukkleus isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Nukkleus's main competitors or similar companies to consider before investing?
When looking at Nukkleus, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Salesforce
CRM235.01B Technology Software - Application -5.95% 50.27% Intuit
INTU200.06B Technology Software - Application 6.91% 47.76% Eplus
PLUS1.92B Technology Software - Application -22.88% 49.90% Matterport
MTTR1.76B Technology Software - Application N/A N/A Olo
OLO1.73B Technology Software - Application 85.66% 32.86% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Nukkleus Inc. Warrant? (e.g., ROE, Debt/Equity)
- To get a sense of Nukkleus's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 120.02%, the Debt to Equity ratio from the most recent quarter is -0.04, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for NUKKW?
- Looking at Nukkleus's growth, its revenue over the trailing twelve months (TTM) was $6M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of -100.00%.
- How much of NUKKW stock is held by insiders and institutions?
- Wondering who owns Nukkleus stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.